What is the recommended treatment for typhoid fever?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Treatment for Typhoid Fever

The recommended first-line treatment for typhoid fever is azithromycin at a dosage of 20 mg/kg/day for 7 days, especially in areas with high resistance to fluoroquinolones and for vulnerable populations such as children and pregnant women. 1

Treatment Options Based on Antibiotic Sensitivity

Treatment should be guided by local resistance patterns and strain sensitivity:

For Different Strains of Salmonella Typhi:

Strain Recommended Treatment Alternative Options
Fully sensitive Azithromycin Fluoroquinolones, chloramphenicol, amoxicillin, trimethoprim-sulfamethoxazole
Multidrug-resistant Fluoroquinolones or cefixime Azithromycin
Quinolone-resistant Azithromycin or ceftriaxone Cefixime

Important Considerations:

  • Azithromycin achieves faster fever clearance times (<4 days) and higher clinical cure rates compared to fluoroquinolones, with relapse rates <3% 1
  • Ceftriaxone is an effective alternative, typically administered at 75 mg/kg/day (maximum 2g/day) intravenously in two divided doses 2, 3
  • Fluoroquinolones like ciprofloxacin should be avoided in south Asia due to high resistance rates (96% of Salmonella Typhi isolates show resistance to nalidixic acid and 58% are multidrug-resistant) 1, 4

Special Population Considerations

  • Children: Azithromycin is preferred; alternatively, ceftriaxone at 75 mg/kg/day can be used 2
  • Pregnant women: Avoid fluoroquinolones; use azithromycin, ampicillin, cefotaxime, or ceftriaxone 1
  • Immunocompromised patients: Consider longer duration of therapy with ceftriaxone or azithromycin 1
  • HIV-infected persons with Salmonella septicemia: Require long-term therapy to prevent recurrence 1

Treatment Duration and Monitoring

  • Standard treatment duration: 7 days for azithromycin 1, 4
  • For ceftriaxone: A flexible-duration approach until defervescence plus 5 additional days has shown good results 2
  • Consider changing antibiotics if no improvement is seen within 2 days of starting treatment 1
  • Monitor for defervescence, which typically occurs within 4-5 days of starting appropriate therapy 2, 3

Prevention Strategies

  • Typhoid vaccination is recommended for travelers to endemic areas 1
  • Proper hand hygiene is essential, especially after using the toilet and before food preparation 1
  • Careful selection of food and drink in endemic areas, as vaccines are not 100% effective 5

Common Pitfalls and Caveats

  • Avoid antimotility agents as they may worsen outcomes in enteric infections 1
  • Don't rely solely on clinical presentation for diagnosis; blood cultures are essential for confirmed diagnosis 1
  • Beware of altered symptom presentation in patients who have previously used antimicrobials 4
  • Don't underestimate the importance of follow-up in high-risk individuals such as food handlers, healthcare workers, or childcare providers 1
  • Remember that resistance patterns vary geographically; treatment should be guided by local resistance patterns 1, 4

Complications Management

  • Surgical intervention is often necessary for vascular infections and endocarditis 1
  • Life-threatening complications can arise in the second week of untreated illness 4
  • Household contacts should be evaluated for asymptomatic carriage 1

The evidence strongly supports azithromycin as the current first-line treatment for typhoid fever due to its efficacy, safety profile, and effectiveness against resistant strains, with ceftriaxone as an excellent alternative, particularly for severe cases requiring parenteral therapy.

References

Guideline

Infection Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Enteric (typhoid and paratyphoid) fever.

Lancet (London, England), 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.